Immunologic Tolerance and Autoimmunity
Immunologic Tolerance and Autoimmunity
Immunologic Tolerance and Autoimmunity
Retno Murwanti, DVM, MSc, PhD.! Dept. of Pharmacology and Clinical Pharmacy! Faculty of Pharmacy! Universitas Gadjah Mada! 2013
"1
Immunologic Tolerance
"2
Immunologic Tolerance
!Antigens that induce tolerance are
called tolerogens, or tolerogenic antigens, to distinguish them from immunogens, which generate immunity. !
Immunologic tolerance is dened as unresponsiveness to an antigen that is induced by previous exposure to that antigen.
!Elucidating the mechanisms of selftolerance is the key to understanding the pathogenesis of autoimmunity.
!3
T Lymphocyte Tolerance
Introduction
Tolerance in CD4+ helper T lymphocytes is an effective way of preventing immune responses to protein antigens because helper T cells are necessary inducers of both cell-mediated and humoral immune responses to proteins.! Immunologists have also developed experimental models for studying tolerance in CD4+ T cells that have proved to be quite informative. ! Many of the therapeutic strategies that are being developed to induce tolerance to transplants and autoantigens are targeted to these T cells.
Tolerance in T Cells
During their maturation in the thymus, many immature T cells that recognize antigens with high avidity are deleted and some of the surviving cells in the CD4+ lineage develop into regulatory T cells ! Some self-reactive CD4+ T cells that see self antigens in the thymus are not deleted but instead differentiate into regulatory T cells specic for these antigens
The signals involved in a normal immune response (A) and the three major mechanisms of peripheral T cell tolerance (B) !
Regulatory T Cell!
(Treg)
Regulatory T cells are generated by self antigen recognition in the thymus (natural regulatory cells) and by antigen recognition in peripheral lymphoid organs (inducible or adaptive regulatory cells). ! The development and survival of these regulatory T cells require IL-2 and the transcription factor FoxP3. ! In peripheral tissues, regulatory T cells suppress the activation and effector functions of other, self-reactive and potentially pathogenic lymphocytes.
Regulatory T cells
a subset of CD4+ T cells whose function is to suppress immune responses and maintain selftolerance.
B Lymphocyte Tolerance
Introduction
Tolerance in B lymphocytes is necessary for maintaining unresponsiveness to thymus-independent self antigens, such as polysaccharides and lipids. ! B cell tolerance also plays a role in preventing antibody responses to protein antigens. ! Experimental studies have revealed multiple mechanisms by which encounter with self antigens may abort B cell maturation and activation.
In general, protein antigens administered subcutaneously or intradermally with adjuvants favor immunity, whereas high doses of antigens administered systemically without adjuvants tend to induce tolerance. ! Reason : adjuvants stimulate innate immune responses and the expression of costimulators on APCs, and in the absence of these second signals, T cells that recognize the antigen may become anergic or die or may differentiate into regulatory cells. ! Many other features of antigens, and how they are administered, may inuence the balance between immunity and tolerance! The oral administration of a protein antigen often leads to suppression of systemic humoral and cell-mediated immune responses to immunization with the same antigen (oral tolerance)! Some systemic infections (e.g., with viruses) may initiate an immune response, but the response is impaired before the virus is cleared, resulting in a state of persistent infection. In this situation, virus-specic T cell clones are present but do not respond normally and are unable to eradicate the infection.
T cells can directly inhibit the activation of CD8 T cells or suppress CD4 helper cells that re required for full CD8+ responses (see Chapter 9). CD8+ T cells that are exposed to hig oncentrations of self antigens may also undergo apoptotic cell death.
Factors That Determine Tolerogenicity of Self Antigens Factors That the Determine the Immunogenicity
and
Table 14-2. Factors That Determine the Immunogenicity and Tolerogenicity of Protein Antigens Features That Favor Tolerance Prolonged Intravenous, mucosal; presence in generative organs Antigens without adjuvants: nonimmunogenic or tolerogenic Low levels of costimulators and cytokines
Factor Persistence Portal of entry; location Presence of adjuvants Properties of antigenpresenting cells
page 3
Autoimmunity
"21
Autoimmunity ?
The state of adaptive immune system responsiveness to self antigens that occurs when mechanisms of self- tolerance fail
Introduction
Early 1900s Paul Erlich :! horor autotoxicus! Immune -mediated inammatory disease
AUTOIMMUNITY
Concepts in autoimmunity
Autoimmunity results from a failure of the mechanisms of selftolerance in T or B cells, which may lead to an imbalance between lymphocyte activation and control mechanisms.! Loss of self-tolerance may result if self-reactive lymphocytes are not deleted or inactivated during or after their maturation and if APCs are activated so that self antigens are presented to the immune system in an immunogenic manner.! Autoimmune diseases may be either systemic or organ specic, depending on the distribution of the autoantigens that are recognized.! Systemic (SLE), Organ specic (MS, diabetes type 1, Myasthenia gravis)! The major factors that contribute to the development of autoimmunity are genetic susceptibility and environmental triggers
Pathogenesis of autoimmunity
HLA-associated disease
Individuals inherit multiple genetic polymorphisms - contribute to disease susceptibility - these genes act with environmental factors to cause the diseases! HLA : MHC molecules expressed on the surface of human cells! Among the genes that are associated with autoimmunity, the strongest associations are with MHC genes.! WHY? class II MHC molecules are involved in the selection and
activation of CD4+ T cells, and CD4+ T cells regulate both humoral and cell-mediated immune responses to protein antigens.!
HLA-associated disease : Rheumatoid arthritis, Type 1 diabetes, Multiple schlerosis, Sistemic Lupus Erythematosus, Ankylosing spondylitis, Celiac disease
Many of the polymorphisms associated with various autoimmune diseases are in genes that inuence the development and regulation of immune responses. ! Different polymorphisms may either protect against disease development or increase the incidence of the disease. ! Example of Genes involved : PTPN22,NOD2l,Insulin,CD25, IL-23 receptor (IL-23R), andATG16.
Single-Gene Abnormalities
The known genes contribute to the established mechanisms of central tolerance (AIRE), generation of regulatory T cells (FoxP3, IL-2, IL-2R), anergy and the function of regulatory T cells (CTLA-4), and peripheral deletion of T and B lymphocytes (Fas, FasL)
Infections may predispose to autoimmunity by several mechanisms:! enhanced expression of costimulators in tissues ! cross-reactions between microbial antigens and self antigens. ! Some infections may protect individuals from autoimmunity, by unknown mechanisms.
Anatomic alterations in tissues, caused by inammation (possibly secondary to infections), ischemic injury or trauma, may lead to the exposure of self antigens that are normally concealed from the immune system. ! Hormonal inuences play a role in some autoimmune diseases.
SLE
Prototypic Immune Complex-Mediated Disease! a chronic, remitting and relapsing, multisystem autoimmune disease that affects predominantly women, with an incidence of 1 in 700 among women between the ages of 20 and 60 years. ! The principal clinical manifestations : rashes, arthritis, and glomerulonephritis, but hemolytic anemia, thrombocytopenia, and CNS involvement are also common.! Many different autoantibodies are found in patients with SLE. The most frequent are antinuclear, particularly anti-DNA, antibodies; others include antibodies against ribonucleoproteins, histones, and nucleolar antigens. ! Immune complexes formed from these autoantibodies and their specic antigens are responsible for glomerulonephritis, arthritis, and vasculitis involving small arteries throughout the body. Hemolytic anemia and thrombocytopenia are due to autoantibodies against erythrocytes and platelets, respectively. ! The principal diagnostic test for the disease is the presence of antinuclear antibodies; antibodies against double-stranded native DNA are specic for SLE.
Clinical trials are under way to test the efcacy of anti-IFN-$ antibodies ! Inhibition of TLR signals are being considered. ! Depleting B cells by use of an antibody against the B cell surface protein CD20. ! An antibody that blocks the B cell growth factor BAFF is now approved for the treatment of SLE.